U.S. flag

An official website of the United States government

NM_003242.6(TGFBR2):c.-193G>A AND Diabetic retinopathy

Germline classification:
Uncertain risk allele (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004021906.1

Allele description [Variation Report for NM_003242.6(TGFBR2):c.-193G>A]

NM_003242.6(TGFBR2):c.-193G>A

Genes:
LOC129936399:ATAC-STARR-seq lymphoblastoid silent region 14158 [Gene]
TGFBR2:transforming growth factor beta receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p24.1
Genomic location:
Preferred name:
NM_003242.6(TGFBR2):c.-193G>A
HGVS:
  • NC_000003.12:g.30606691G>A
  • NG_007490.1:g.5190G>A
  • NM_001024847.3:c.-193G>A
  • NM_001407126.1:c.-193G>A
  • NM_001407127.1:c.-193G>A
  • NM_001407130.1:c.-193G>A
  • NM_001407133.1:c.-476G>A
  • NM_001407134.1:c.-354G>A
  • NM_001407135.1:c.-401G>A
  • NM_001407136.1:c.-486G>A
  • NM_001407137.1:c.-193G>A
  • NM_001407138.1:c.-193G>A
  • NM_001407139.1:c.-193G>A
  • NM_003242.6:c.-193G>AMANE SELECT
  • LRG_779t1:c.-193G>A
  • LRG_779t2:c.-193G>A
  • LRG_779:g.5190G>A
  • NC_000003.11:g.30648183G>A
  • NM_001024847.2:c.-193G>A
  • NM_003242.5:c.-193G>A
Links:
dbSNP: rs886058301
NCBI 1000 Genomes Browser:
rs886058301
Molecular consequence:
  • NM_003242.6:c.-193G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]

Condition(s)

Name:
Diabetic retinopathy
Identifiers:
MONDO: MONDO:0005266; MedGen: C0011884

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005016456Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K And H Uppaluri Personalized Medicine Clinic Variant Classification And Assertion Criteria Updated V 2)
Uncertain risk alleleunknownresearch

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy.

Platania CBM, Leggio GM, Drago F, Salomone S, Bucolo C.

Biochem Pharmacol. 2018 Dec;158:13-26. doi: 10.1016/j.bcp.2018.09.016. Epub 2018 Sep 15.

PubMed [citation]
PMID:
30222965

The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.

Dagher Z, Gerhardinger C, Vaz J, Goodridge M, Tecilazich F, Lorenzi M.

Am J Pathol. 2017 Mar;187(3):627-638. doi: 10.1016/j.ajpath.2016.11.007. Epub 2017 Feb 2.

PubMed [citation]
PMID:
28162229
PMCID:
PMC5397667
See all PubMed Citations (3)

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV005016456.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (3)

Description

Potent mutations in TGFBR2 gene encodes the transforming growth factor that have been associated with angiogenesis and diabetic retinopathy. More clinical studies are needed for stronger association. However, more evidence is required to confer the association of this particular variant rs886058301 with diabetic retinopathy.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024